Federated Hermes, Inc. Intercept Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$42.5 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$9.99 - $18.71 $1.01 Million - $1.9 Million	-101,474 Reduced 59.08%	70,276 $1.3 Million
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $632,766 - $1.33 Million	69,004 Added 67.16%	171,750 $1.9 Million
Q1 2023 May 08, 2023	BUY	$12.53 - $21.71 $1.27 Million - $2.21 Million	101,619 Added 9016.77%	102,746 $1.38 Million
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $12,271 - $17,028	1,057 Added 1510.0%	1,127 $13,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $854 - $1,379	70 New	70 $1,000

Q1 2022 May 13, 2022	SELL	$13.37 - $17.79 $751,367 - $999,762	-56,198 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $802,507 - $1.1 Million	56,198 New	56,198 $915,000
Q2 2020 Aug 13, 2020	SELL	$46.7 - $92.04 $46 - $92	-1 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$48.35 - $118.68 $4.69 Million - $11.5 Million	-96,983 Reduced 100.0%	1 $1,000
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $5.56 Million - $12 Million	96,984 New	96,984 $12 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $57,340 - $78,609	-977 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $10.9 Million - $16.8 Million	-139,588 Reduced 99.3%	977 $78,000
Q1 2019 May 10, 2019	BUY	$91.83 - $120.68 $10.9 Million - $14.3 Million	118,264 Added 530.31%	140,565 $15.7 Million
Q4 2018 Feb 13, 2019	SELL	$85.79 - $126.46 $5.38 Million - $7.93 Million	-62,724 Reduced 73.77%	22,301 $2.25 Million
Q3 2018 Nov 13, 2018	BUY	$88.49 - $127.55 $6.93 Million - $9.98 Million	78,260 Added 1156.84%	85,025 $10.7 Million
Q2 2018 Aug 10, 2018	BUY	$60.0 - $85.67 $61,500 - $87,811	1,025 Added 17.86%	6,765 $568,000
Q1 2018 May 09, 2018	BUY	$52.72 - $67.25 $264,021 - $336,788	5,008 Added 684.15%	5,740 $353,000
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $989 - $1,236	-17 Reduced 2.27%	732 $0
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $42,700 - $88,943	749	749 $43,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account